Search for: ""Wyeth v. Levine" OR "555 U.S. 555"" Results 1 - 20 of 74
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Mar 2022, 7:01 pm by Sean Wajert
Levine, 555 U.S. 555 (2009), particularly with regard to the need in a warnings context that there should be clear evidence that the FDA would have rejected the plaintiff’s proposed alternative label. [read post]
11 Apr 2016, 1:41 pm
Levine, 555 U.S. 555 (2009).So, is there a statutory sameness requirement for biosimilars that the FDA is conveniently forgetting about? [read post]
22 Mar 2016, 7:48 am
Levine, 555 U.S. 555 (2009), defendant has to demonstrate the conflict between state and federal law by “clear evidence. [read post]
17 Nov 2015, 5:00 am
Not quite two years ago, we posted about how, under Wyeth v. [read post]
24 Aug 2015, 5:00 am
Levine, 555 U.S. 555 (2009), that the FDA would not have allowed a developmental delay warning at any time in 2003 that could conceivably have affected the pregnancy at issue in Rheinfrank:Preemption is warranted because there is clear evidence the FDA would not have approved a change to the Depakote label adding a developmental delay warning prior to [plaintiff’s] injury. [read post]
13 Aug 2015, 10:56 am
Levine, 555 U.S. 555 (2009), it appeared that to argue preemption successfully, a brand-name manufacturer must provide “clear evidence” that the FDA would have rejected the relevant label changes. [read post]
21 May 2015, 1:09 pm by Rebecca Tushnet
Levine, 555 U.S. 555 (2009), a preemption case otherwise on all fours with the facts here. [read post]
12 Jan 2015, 12:59 pm
Medtronic, Inc., 552 U.S. 312 (2008), and Wyeth v. [read post]
7 Jan 2015, 6:54 am
Levine, 555 U.S. 555 (2009), has no bearing because it wasn’t a design claim at all. [read post]
5 Jan 2015, 1:26 pm
  The supporting citations are only from Wyeth v. [read post]
6 Nov 2014, 5:00 am
Levine, 555 U.S. 555 (2009)), invoked greater ire from us than the atrocity in State ex rel. [read post]